Loading clinical trials...
Loading clinical trials...
A Rapid Diagnostic of Risk in Hospitalized Patients With COVID-19, Sepsis, and Other High-Risk Conditions to Improve Outcomes and Critical Resource Allocation Using Machine Learning
Conditions
Interventions
eCARTv5 clinical deterioration monitoring
Standard of care control
Locations
3
United States
Yale New Haven Health System
New Haven, Connecticut, United States
BayCare Health System
Clearwater, Florida, United States
University of Wisconsin Health
Madison, Wisconsin, United States
Start Date
December 31, 2024
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
July 29, 2025
NCT06650501
NCT07172451
NCT04955210
NCT04850456
NCT07179276
NCT05267821
Lead Sponsor
AgileMD, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions